Kamran S Moghissi

No ORCID on file · 16 papers in corpus · active 1975-2005

Study types

  • article 11
  • book-chapter 3
  • review 2

Condition tags

  • endometriosis 11
  • mesh:D004715 8
  • infertility 6
  • adenomyosis 1
article 2005
Causes of Infertility as Predictors of Subsequent Cancer Risk
Epidemiology (Cambridge, Mass.) ·doi:10.1097/01.ede.0000164812.02181.d5

BACKGROUND: Although studies have found elevated risks of certain cancers linked to infertility, the underlying reasons remain unclear. METHODS: In a retrospective cohort study of 12,193 U.S. women evaluated for infertility between 1965 and…

article 2004
Ovarian cancer risk associated with varying causes of infertility
Fertility and Sterility ·doi:10.1016/j.fertnstert.2004.02.109
article 2003
Causes of infertility and ovarian cancer risk
·doi:10.1016/s0015-0282(03)02039-9
review 1999
Medical Treatment of Endometriosis
Clinical obstetrics and gynecology ·doi:10.1097/00003081-199909000-00016

Wayne State University/Hutzel Hospital, Detroit, Michigan Correspondence: Kamran S. Moghissi, MD, Professor, Department of Obstetrics & Gynecology, Division of Reproductive Endocrinology & Infertility, Wayne State University/Hutzel Hospital…

article 1998
Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00166-6
article 1996
Add-back therapy in the treatment of endometriosis: the North American experience.
British journal of obstetrics and gynaecology
book-chapter 1995
Approach to the Patient With Suspected Endometriosis
·doi:10.1007/978-1-4613-8404-5_7
article 1993
Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist
Fertility and Sterility ·doi:10.1016/s0015-0282(16)55703-3
article 1988
Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
The New England journal of medicine ·doi:10.1056/nejm198802253180805

Treatment with nafarelin, a gonadotropin-releasing hormone agonist, reversibly inhibits ovarian function and induces hypoestrogenemia. To determine the efficacy of such hormonal manipulation in the treatment of endometriosis, we randomly as…

review 1988
Treatment of Endometriosis with Estrogen-Progestin Combination and Progestogens Alone
Clinical obstetrics and gynecology ·doi:10.1097/00003081-198812000-00008
article 1987
Comparison of different treatment modalities of endometriosis in infertile women
·doi:10.1016/s0015-0282(16)49933-4
article 1987
Comparison of Different Treatment Modalities of Endometriosis in Infertile Women
·doi:10.1097/00006254-198710000-00021

Over the past three decades, medical management of endometriosis has included high-dose synthetic estrogen, diethylstilbestrol, androgens, progestins (with or without estrogen), danazol, a synthetic derivative of 17-ethinyl testosterone, an…

book-chapter 1987
Comparison of Different Treatment Modalities of Endometriosis in Infertile Women
·doi:10.1159/000414892
book-chapter 1987
Evaluation of a GnRH Agonist (Nafarelin) versus Danazol for Treatment of Endometriosis
·doi:10.1159/000414897
article 1976
MANAGEMENT OF ENDOMETRIOSIS WITH ORAL MEDROXYPROGESTERONE ACETATE
Obstetrics and gynecology ·doi:10.1097/00006254-197609000-00021

Efficacy of oral medroxyprogesterone acetate (MPA) was assessed in 35 women with an established diagnosis of endometriosis (33 pelvic and 2 abdominal). MPA was given in a dosage of 30 mg daily for 90 days. Results indicated improvement or r…

article 1975
Correlation between Hysterosalpingography and Pelvic Endoscopy for the Evaluation of Tubal Factor
Fertility and Sterility ·doi:10.1016/s0015-0282(16)41531-1